𝔖 Bobbio Scriptorium

✦ LIBER ✦

Angiotensin converting enzyme inhibitors: Are they preferred first-line therapy?

✍ Scribed by Stephen P. Glasser

Book ID: 107540878
Publisher: Springer
Year: 2000
Tongue: English
Weight: 249 KB
Volume: 2
Category: Article
ISSN: 1522-6417
DOI: 10.1007/s11906-000-0043-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of angiotensin I converting enzym

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

✍ Stefan Wilop; Sabine von Hobe; Martina Crysandt; Albert Esser; Rainhardt Osieka; 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 319 KB

Long-term efficacy of a new, fixed, very

Long-term efficacy of a new, fixed, very-low-dose angiotension converting enzyme inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients

✍ George Mansour; Janette Mansour 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 76 KB